Testing a weight loss injection for people with overweight or obesity
Part of Hormones & metabolism clinical trials.
This study tests an injectable medication called Olatorepatide to help people with overweight or obesity lose weight. It is only for people without diabetes who meet specific body mass index (BMI) requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and have a BMI of 30 or higher (or a BMI of 27 or higher with a weight-related health condition like high blood pressure or sleep apnea).
- You do not have type 1 or type 2 diabetes.
- Your weight has not changed by more than 11 pounds in the last 3 months.
- You have not had weight-loss surgery.
- You have not had pancreatitis or gallbladder problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.
This trial tests an investigational injection called HRS-4729 for weight loss in people with obesity. It checks if the drug is safe and effective when used along with diet and exercise.
This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.
This study tests an investigational weight-loss injection, IN-B00009, for adults with obesity or overweight who don't have diabetes. It aims to see if the drug is safe and effective for helping you lose weight, along with diet and exercise.
This trial tests a once-weekly injection (tirzepatide) versus a placebo to help people who are obese or overweight with related health conditions lose weight. You may qualify if you have tried to lose weight through diet before, but have not been successful.
This study tests an experimental medicine (eloralintide) to see if it can help people with overweight or obesity lose weight without having diabetes. The medicine works by affecting hormones that help control appetite and body weight.
Hear when a new Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.